Trial NCT02059265

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2014-00209
Secondary IDs: GOG-0283 NCI-2014-00209 U10CA027469 U10CA180868

Last trial update was posted on 2023-08-01

MeSH Interventions

Dasatinib

MeSH Conditions

Adenocarcinoma, Clear Cell Carcinoma Cystadenocarcinoma Recurrence

Other Conditions

Endometrial Clear Cell Adenocarcinoma Ovarian Clear Cell Cystadenocarcinoma Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Recurrent Uterine Corpus Cancer

Stopping Reasons

Interim monitoring

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID